Back to Authors

Cao, Jenny J

0000-0002-7167-004X

Mayo Clinic

Department of Internal Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.

Citations 4

A 5-Year Epidemiological Study of Monomicrobial Enterococcal Bloodstream Infection in a Population-Based Cohort
Bayless, David , Baddour, Larry M. , Lahr, Brian D. , Hagan, Grace , Cao, Jenny Jia Ling , DeSimone, Daniel C. , Bayless, David R , Hagan, Grace A , Cao, Jenny J , Baddour, Larry , DeSimone, Daniel C

Open Forum Infectious Diseases | August 20, 2025 | Volume: 12 | Issue: 9 | Pages: No page available

10.1093/ofid/ofaf506 Get It

Abstract Background The incidence, epidemiology, and clinical characteristics of enterococcal bloodstream infection (BSI) have not previously been studied on a population-based level in the United States. Methods We utilized the Expanded Rochester Epidemiology Project medical records linkage system to conduct a contemporary 5-year, retrospective, population-based study of monomicrobial enterococcal (ME) BSI among adult residents of 8 counties in southeast Minnesota from January 1, 2018 to December 31, 2022. Results A total of 109 cases of ME-BSI were identified. The overall age- and sex-adjusted incidence rate was 6.7 per 100 000 person-years (95% confidence interval, 5.4–7.9). Multivariable analysis revealed that male sex (P < .001) and older age (P < .001) were each independently associated with increased incidence, whereas no temporal association was demonstrated (year effect, P = .475). The median age of incident cases was 76.8 years (interquartile range, 65.0–83.3). Urinary tract source was the most common presumed source (42.2%), and Enterococcus faecalis was the predominant (83.5%) pathogen. Overall, 14.4% of patients met modified Duke criteria for definite infective endocarditis. Cumulative mortality was 28.4% at 12 weeks and 43.1% at 1 year. Conclusions In this population-based study, ME-BSI was significantly associated with older age and male sex. There was a high rate of mortality at 12 weeks and 1 year, with ∼1 out of 7 cases complicated by definite infective endocarditis. These findings underscore the importance of ongoing investigation of this syndrome.
Esophageal‐Pericardial Fistula: A Systematic Review of Etiology, Diagnostic Features, Management, and Outcomes
Cao, Jenny Jia Ling , Saha, Bibek , Gerberi, Dana , Agarwal, Siddharth , Codipilly, Don C. , Deshmukh, Abhishek , Gerberi, Danielle J , Deshmukh, Abhishek J , Agarwal, Siddharth , Cao, Jenny J

Journal of Cardiovascular Electrophysiology | July 29, 2025 | Volume: 36 | Issue: 9 | Pages: 2382-2396

10.1111/jce.70029 Get It

ABSTRACTBackgroundEsophageal‐pericardial fistula (EPF) is rare with an incidence of 0.016%–0.04%. With novel procedures involving intracardiac or esophageal instrumentation in the last few decades, including atrial fibrillation (AF) ablation, further understanding of this unique entity is warranted. In this systematic review, we summarize the etiology, diagnostic features, management, and outcomes of EPF.MethodsA librarian conducted a systematic literature review of case reports/series describing adults diagnosed with EPF through 7 major databases/registries from inception to 7/30/2024.ResultsOne hundred twenty patients from 115 papers met the inclusion criteria. Median age(IQR) was 57(44–67) years, with a male predominance (73.7%). The primary etiology of EPF shifted from benign esophageal diseases before 2000 to AF ablation on/after 2000. Median time(IQR) from AF ablation to EPF presentation/diagnosis was 17(13–23) days. Chest pain (70.8%) and pneumopericardium (90.0%) were, respectively, the most common presenting symptom and pericardial finding. Water‐soluble contrast esophagram (WSCE) had the highest diagnostic sensitivity (82.8%). Management included surgery (47.5%), stent placement (22.5%), combined surgery/stenting (19.2%), and conservative (10.8%). Overall mortality was 37.5%; median(IQR) time to death was 20(9–41) days. EPF from malignancy had poorer survival than those from benign esophageal causes (HR 2.65 [1.36–5.17]; p = 0.004) and cardiac ablation (HR 5.74 [2.41–13.65]; p < 0.0001). Patients who received any intervention (HR 0.28 [0.13‐0.57]; p = 0.0005) or had confirmed EPF resolution (HR 0.27 [0.12–0.59]; p = 0.0009) demonstrated better survival. There was no difference in survival between surgery and stenting alone (p = 0.91).ConclusionsAF ablation is now the leading etiology of EPF. Given its high mortality, a high degree of clinical suspicion is essential in those presenting with key signs/symptoms following AF ablation to enable urgent diagnosis and multi‐disciplinary management. WSCE may be the diagnostic modality to perform, given its high sensitivity. Future studies are warranted to investigate whether stenting should be the primary management given possible non‐inferiority to surgery.
Pseudo-Severe Mitral Stenosis From Obesity-Related HFpEF and Atrial Myopathy
Cao, Jenny Jia Ling , Miranda, William R. , Borlaug, Barry A. , Reddy, Yogesh N.V. , Nishimura, Rick , Borlaug, Barry A , Cao, Jenny J

Circulation: Heart Failure | January 28, 2025 | Volume: 18 | Issue: 3 | Pages: No page available

10.1161/circheartfailure.124.012703 Get It

Not all COVID patients have thrombosis: a case of Coxiella burnetii endocarditis
Cao, Jenny Jia Ling , Alabdaljabar, Mohamad S. , Oh, Jae K. , Pislaru, Sorin V. , Sabbah, Michael S. , Alabdaljabar, Mohamad S , Cao, Jenny J

European Heart Journal - Case Reports | November 14, 2024 | Volume: 8 | Issue: 12 | Pages: No page available

10.1093/ehjcr/ytae602 Get It